Concentration of circulating tumour DNA in patients with metastatic gastric cancer and its prognostic significance
By:
References
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011 Apr;61(2):69–90.
- Siegel, RL, Miller, KD, Fuchs, H, Jemal, A. Cancer Statistics, 2021. CA Cancer J Clin. 2021: 71: 7–33. <a href="https://doi.org/10.3322/caac.21654." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3322/caac.21654.</a>
- Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, et al. (eds). SEER cancer statistics review, 1975–2014, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017.
- Bertuccio P, Rosato V, Andreano A, Ferraroni M, Decarli A, Edefonti V, et al. Dietary patterns and gastric cancer risk: a systematic review and meta-analysis. Ann Oncol Off J Eur Soc Med Oncol. 2013 Jun;24(6):1,450–8.
- Ma J-L, Zhang L, Brown LM, Li J-Y, Shen L, Pan K-F, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst. 2012 Mar 21;104(6):488–92.
- Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med. 2009 Jul 21;151(2):121–8.
- Alix-Panabières C, Schwarzenbach H, Pantel K. Circulating tumor cells and circulating tumor DNA. Annu Rev Med. 2012;63:199–215.
- Kohler C, Barekati Z, Radpour R, Zhong XY. Cell-free DNA in the circulation as a potential cancer biomarker. Anticancer Res. 2011 Aug;31(8):2,623–8.
- Jin H, Ma Y, Shen Q, Wang X. Circulating methylated DNA as biomarkers for cancer detection. Methylation – DNA RNA Histones Dis Treat [Internet]. 2012 Nov 28 [cited 2019 May 4]; Available from: https://www.intechopen.com/books/methylation-from-dna-rna-and-histones-to-diseases-and-treatment/circulating-methylated-dna-as-biomarkers-for-cancer-detection.
- Alix-Panabieres, C., Schwarzenbach, H., & Pantel, K.. Circulating tumor cells and circulating tumor DNA. Annu Rev Med, 2012;63,199–215.
- Ghossein, RA, Bhattacharya, S, Rosai, J. Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res. 1999;5:1,950–1,960.
- Mocellin, S., Keilholz, U., Rossi, C. R., Nitti, D. Circulating tumor cells: the ‘leukemic phase’ of solid cancers. Trends Mol Med. 2006;12:130–139.
- Chimonidou, M., Strati, A., Tzitzira, A., Sotiropoulou, G., Malamos, N., Georgoulias, V., et al. DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells. Clin Chem. 2011;57:1,169–1,177.
- Kohler, C., Barekati, Z., Radpour, R., Zhong, X. Y. Cell-free DNA in the circulation as a potential cancer biomarker. Anticancer Res. 2011;31:2,623–2,628.
- Jin H, Ma Y, Shen Q, Wang X. Circulating methylated DNA as biomarkers for cancer detection. Methylation – DNA RNA Histones Dis Treat [Internet]. 2012 November 28 [cited 2019 May 4]; Available from: https://www.intechopen.com/books/methylation-from-dna-rna-and-histones-to-diseases-and-treatment/circulating-methylated-dna-as-biomarkers-for-cancer-detection.
- Chen H-M, Fang J-Y. Epigenetic biomarkers for the early detection of gastrointestinal cancer. Gastrointest Tumors. 2014 May;1(4):201–8.
- Karamitrousis EI, Balgkouranidou I, Xenidis N, Amarantidis K, Biziota E, Koukaki T, et al. Prognostic role of RASSF1A, SOX17 and Wif-1 promoter methylation status in cell-free DNA of advanced gastric cancer patients. Technol Cancer Res Treat. 2021 Jan–Dec;20:1533033820973279. doi: <a href="https://doi.org/10.1177/1533033820973279." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1177/1533033820973279.</a> PMID: 33928818; PMCID: PMC8113658.
- Balgkouranidou I, Matthaios D, Karayiannakis A, Bolanaki H, Michailidis P, Xenidis N, et al. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients. Mutat Res. 2015 Aug;778:46–51.
- Bu J, Lee TH, Jeong WJ, Poellmann MJ, Mudd K, Eun HS, et al. Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer. PLoS One. 2020 Dec 2;15(12):e0242145. doi: <a href="https://doi.org/10.1371/journal.pone.0242145." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1371/journal.pone.0242145.</a> PMID: 33264292; PMCID: PMC7710035.
Language: English
Page range: 72 - 76
Submitted on: Oct 14, 2021
Accepted on: Dec 23, 2021
Published on: May 7, 2022
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Keywords:
Related subjects:
© 2022 E. Karamitrousis, I. Balgkouranidou, N. Xenidis, K. Amarantidis, E. Biziota, T. Koukaki, S. Kakolyris, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.